Ross J. Mangano is Director at BIOSANTE PHARMACEUTICALS INC (BPAX). They have made 16 open-market trades across 3 companies since 2006, most recently 2014-09-15.
CIK 0001013724
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
16 open-market purchases totalling $1.4M since 2006, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIP | BUY | 2014-09-15 | 2014-09-16 | $27.49 | $82K | -18.3% | -1.0% | -1.0% |
| ANIP | BUY | 2014-05-07 | 2014-05-07 | $30.38 | $61K | -18.3% | -1.0% | -1.0% |
| ANIP | BUY | 2013-11-07 | 2013-11-12 | $11.27 | $101K | -18.3% | -1.0% | -1.0% |
| ANIP | BUY | 2013-08-20 | 2013-08-22 | $7.47 | $75K | -18.3% | -1.0% | -1.0% |
| BPAX | BUY | 2011-08-12 | 2011-08-12 | $2.40 | $60K | N/A | N/A | N/A |
| BPAX | BUY | 2011-08-05 | 2011-08-05 | $2.21 | $177K | N/A | N/A | N/A |
| BPAX | BUY | 2010-12-07 | 2010-12-08 | $1.47 | $29K | N/A | N/A | N/A |
| BPAX | BUY | 2008-12-29 | 2008-12-30 | $1.19 | $30K | N/A | N/A | N/A |
| BPAX | BUY | 2008-05-12 | 2008-05-13 | $3.59 | $54K | N/A | N/A | N/A |
| BPAX | BUY | 2008-01-04 | 2008-01-07 | $3.73 | $187K | N/A | N/A | N/A |
| BPAX | BUY | 2007-12-20 | 2007-12-21 | $3.98 | $100K | N/A | N/A | N/A |
| BPAX | BUY | 2007-12-19 | 2007-12-20 | $3.69 | $185K | N/A | N/A | N/A |
| BPA | BUY | 2006-12-26 | 2006-12-26 | $2.69 | $40K | N/A | N/A | N/A |
| BPA | BUY | 2006-11-16 | 2006-11-17 | $1.50 | $150K | N/A | N/A | N/A |
| BPA | BUY | 2006-07-19 | 2006-07-20 | $1.90 | $28K | N/A | N/A | N/A |
| BPA | BUY | 2006-07-14 | 2006-07-17 | $1.92 | $26K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.